We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Academic Drug Discovery: Repurposing to treat disease

Article   Jun 30, 2017 | by Adam Tozer PhD, Science Writer for Technology Networks

 
Academic Drug Discovery: Repurposing to treat disease

Adam Tozer PhD

Science Writer

 
 
Advertisement
 

RELATED ARTICLES

COVID-19: Screening Antiviral Drugs Using SARS-CoV-2 Infection Models

Article

Researchers from Queen’s University Belfast will screen approximately 1,000 drugs, which have already received regulatory approval for other indications, to ascertain if they can reduce virus infection or replication and virus-induced inflammatory responses in airway epithelial cell models and to determine if they can therefore be repurposed to treat COVID-19 patients.

READ MORE

COVID-19 – Accelerating Vaccine Development and Manufacturing

Article

Technology Networks spoke with Dr Paul Hodgson, Associate Director of Business Development at VIDO-InterVac to learn more about their experience working with coronaviruses, the organization's manufacturing facilities, and the other antivirals and therapeutics they are currently testing in relation to COVID-19.

READ MORE

STREAM: Six Strategies That Can Help Your Mental Health During Coronavirus Isolation

Article

One in four people on earth are currently in lockdown related to the spread of the novel coronavirus SARS-CoV-2. In this article, we look at some expert advice at how to cope with the impacts of this isolation on your mental health.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Neuroscience Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE